Molecular Oncology: Diagnostic and Prognostic Assessment of Human Cancers in the Clinical Laboratory

References

• Coleman W B, Tsongalis G J. Molecular mutations in human neoplastic disease: application of nucleic acid technology in the assessment of familial risk, diagnosis, and prognosis of human cancers. Molecular Diagnostics: For the Clinical Laboratorian, W B Coleman, G J Tsongalis. Humana Press, Totowa, NJ 1997; 293–316
   Google Scholar
• Tsongalis G J. An overview of medical genetics. Molecular Diagnostics: For the Clinical Laboratorian, W B Coleman, G J Tsongalis. Humana Press, Totowa, NJ 1997; 217–228
   Google Scholar
• Tsongalis G J, Berman M M. Application of forensic identity testing in a clinical setting. Diagn Mol Pathol 1997; 6: 111–114
   PubMed Web of Science ®Google Scholar
• Tsongalis G J, Anamani D E, Wu A HB. Identification of urine specimen donors by the PM + DQA1 amplification and typing kit. J Forens Sci 1996; 41: 1031–1034
   PubMed Web of Science ®Google Scholar
• Aslanzadeh J. Molecular techniques in laboratory diagnosis of infectious diseases. Molecular Diagnostics: For the Clinical Laboratorian, W B Coleman, G J Tsongalis. Humana Press, Totowa, NJ 1997; 341–360
   Google Scholar
• Coleman W B, Tsongalis G J. Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin Chem 1995; 41: 644–657
   PubMed Web of Science ®Google Scholar
• Rezuke W N, Abernathy E C, Tsongalis G J. Molecular diagnosis of B and T cell lymphomas: fundamental principles and clinical applications. Clin Chem 1997; 43: 1814–1823
   PubMed Web of Science ®Google Scholar
• Rezuke W N, Abernathy E C. Molecular genetics and the diagnosis of hematological malignancies. Molecular Diagnostics: For the Clinical Laboratorian, W B Coleman, G J Tsongalis. Humana Press, Totowa, NJ 1997; 317–339
   Google Scholar
• Foulds L. The natural history of cancer. J Chronic Dis 1958; 8: 2–37
   PubMedGoogle Scholar
• Nowell P. The clonal evolution of tumor cell populations. Science 1976; 194: 23–38
   PubMed Web of Science ®Google Scholar
• Weinberg R A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49: 3713–3721
   PubMed Web of Science ®Google Scholar
• Bishop J M. Molecular themes in oncogenesis. Cell 1991; 64: 235–248
   PubMed Web of Science ®Google Scholar
• Renan M J. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinogen 1993; 7: 139–146
   PubMed Web of Science ®Google Scholar
• Loeb L A, Christians F C. Multiple mutations in human cancers. Mutat Res 1996; 350: 279–286
   PubMed Web of Science ®Google Scholar
• Sugarbaker J P, Gunderson L L, Wittes R E. Colorectal cancer. Cancer: Principles and Practice of Oncology, V T De Vita, Jr, S Hellman, S A Rosenberg. J.B. Lippin-cott, Philadelphia 1985
   Google Scholar
• Cohen A M, Minsky B D, Schilsky R L. Cancer of the colon. Cancer: Principles and Practice of Oncology, 5th edition, V T De Vita, Jr, S Hellman, S A Rosenberg. Lip-pincott-Raven, Philadelphia 1997
   Google Scholar
• Chabner B A, Haluska F G, Talcott J A. Screening strategies for cancer. JAMA 1997; 277: 1475–1476
   PubMed Web of Science ®Google Scholar
• Livingston D M. Genetics is coming to oncology. JAMA 1997; 277: 1476–1477
   PubMed Web of Science ®Google Scholar
• Geller G, Botkin J R, Green M J, et al. Genetic testing for susceptibility to adult-onset cancer. JAMA 1997; 277: 1467–1474
   PubMed Web of Science ®Google Scholar
• Sidransky D. Molecular screening-How long can we afford to wait?. J Natl Cancer Inst 1994; 86: 955–956
   PubMed Web of Science ®Google Scholar
• Mao L, Sidransky D. Cancer screening based on genetic alterations in human tumors. Cancer Res 1994; 54: 1939S–1940S
   PubMed Web of Science ®Google Scholar
• Sidransky D. Molecular markers in cancer: Can we make better predictions?. Int J Cancer 1995; 64: 1–2
   PubMed Web of Science ®Google Scholar
• Anderson M W, Reynolds S H, You M, et al. Role of proto-oneo-gene activation in carcinogenesis. Environ Health Perspect 1992; 98: 13–24
   PubMed Web of Science ®Google Scholar
• Cooper G M. Oncogenes. 2nd edition. Jones and Bartiett Publishers, Boston 1995
   Google Scholar
• Marshall C J. Tumor suppressor genes. Cell 1991; 64: 313–326
   PubMed Web of Science ®Google Scholar
• Friend S. p53: a glimpse at the puppet behind the shadow play. Science 1994; 265: 334–335
   PubMed Web of Science ®Google Scholar
• Levine A J. p53. the cellular gatekeeper for growth and division. Cell 1997; 88: 323–331
   PubMed Web of Science ®Google Scholar
• Paulovich A G, Toczyski D P, Hartwell L H. When checkpoints fail. Cell 1997; 88: 315–321
   PubMed Web of Science ®Google Scholar
• Hartwell L H, Weinert T A. Checkpoints: controls that ensure the order of cell cycle events. Science 1989; 246: 629–634
   PubMed Web of Science ®Google Scholar
• Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992; 71: 543–546
   PubMed Web of Science ®Google Scholar
• Hamel P A, Hanley-Hyde J. G1 cyclins and control of the cell division cycle in normal and transformed cells. Cancer Invest 1997; 15: 143–152
   PubMed Web of Science ®Google Scholar
• Sancar A, Sancar G B. DNA repair enzymes. Ann Rev Biochem 1988; 57: 29–67
   PubMed Web of Science ®Google Scholar
• Kaufmann W K. Pathways of human cell postreplication repair. Carcinogenesis 1989; 10: 1–11
   PubMed Web of Science ®Google Scholar
• Naegeli H. Mechanisms of DNA damage recognition in mammalian nucleotide excision repair. FASEB J 1995; 9: 1043–1050
   PubMed Web of Science ®Google Scholar
• Eshleman J R, Markowitz S D. Mismatch repair defects in human carcinogenesis. Hum Mol Genet 1996; 5: 1489–1494
   PubMed Web of Science ®Google Scholar
• Umar A, Kunkel T A. DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur J Biochem 1996; 238: 297–307
   PubMedGoogle Scholar
• Cohen S M, Ellwein L B. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 1991; 51: 6493–6505
   PubMed Web of Science ®Google Scholar
• Cohen S M, Ellwein L B. Cell proliferation in carcinogenesis. Science 1990; 249: 1007–1011
   PubMed Web of Science ®Google Scholar
• Hunter T. Oncoprotein networks. Cell 1997; 88: 333–346
   PubMed Web of Science ®Google Scholar
• Zambetti G P, Levine A J. A comparison of the biological activities of wild-type and mutant p53. FASEB J 1993; 7: 855–865
   PubMed Web of Science ®Google Scholar
• Milner J. Forms and functions of p53. Semin Cancer Biol 1994; 5: 211–219
   PubMed Web of Science ®Google Scholar
• Hollingsworth R E, Hensely C E, Lee W H. Retinoblastoma protein and the cell cycle. Curr Opin Genet Develop 1993; 3: 55–62
   PubMedGoogle Scholar
• Perry M E, Levine A J. Tumor-suppressor p53 and the cell cycle. CUIT Opin Genet Develop 1993; 3: 50–54
   PubMedGoogle Scholar
• Bos J L. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682–4689
   PubMed Web of Science ®Google Scholar
• Hollstein M., Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Greenblatt M S, Bennett W P, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855–4878
   PubMed Web of Science ®Google Scholar
• Pines J. Cyclins and their associated cyclin-dependent kinases in the human cell cycle. Biochem Soc Trans 1993; 21: 921–925
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C. Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 1995; 147: 454–560
   Google Scholar
• Spitz M R, Bondy M L. Genetic susceptibility to cancer. Cancer 1993; 72: 991–995
   PubMed Web of Science ®Google Scholar
• Friedberg E C. DNA Repair. W.H. Freeman, New York 1985
   Google Scholar
• Weeda G., Hoeijmakers J HJ, Bootsma D. Genes controlling nucleotide excision repair in eukaryotic cells. BioEssays 1993; 15: 249–258
   PubMed Web of Science ®Google Scholar
• Sancar A. Mechanisms of DNA excision repair. Science 1994; 266: 1954–1956
   PubMed Web of Science ®Google Scholar
• Bhagwat A S. Restriction enzymes: properties and use. Methods Enzymol 1992; 216: 199–224
   PubMed Web of Science ®Google Scholar
• McClelland M, Nelson M. The effect of site-specific DNA meth-ylation on restriction endonucleases and DNA modification methyltranbsferases–a review. Gene 1988; 74: 291–304
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. Second Edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1989
   Google Scholar
• Harwood A J. Basic DNA and RNA Protocols. Humana Press, Totowa, NJ 1996
   Google Scholar
• Southern E M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503–517
   PubMed Web of Science ®Google Scholar
• Presnell S C. Nucleic acid blotting techniques: theory and practice. Molecular Diagnostics: For the Clinical Laboratorian, W B Coleman, G J Tsongalis. Humana Press, Totowa, NJ 1997; 6.3–87
   Google Scholar
• Feinberg A P, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6–13
   PubMed Web of Science ®Google Scholar
• Feinberg A P, Vogelstein B. Addendum: a technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984; 137: 266–267
   PubMed Web of Science ®Google Scholar
• Rigby P WJ, Dieckmann M, Rhodes C, et al. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol 1977; 113: 237–251
   PubMed Web of Science ®Google Scholar
• Saiki R K, Scharf S, Faloona F, et al. Enzymatic amplification of (-globin genomic sequences and restriction site analysis of sickle cell anemia. Science 1985; 230: 1350–1354
   PubMed Web of Science ®Google Scholar
• Mullis K B, Faloona F A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987; 155: 335–350
   PubMed Web of Science ®Google Scholar
• Saiki R K, Gelfand D H, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–491
   PubMed Web of Science ®Google Scholar
• Sorscher D H. DNA amplification techniques: an overview. Molecular Diagnostics: For the Clinical Laboratorian, W B Coleman, G J Tsongalis. Humana Press, Totowa, NJ 1997; 89–101
   Google Scholar
• Cheng S, Fockler C, Barnes W M, et al. Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci USA 1994; 91: 5695–5699
   PubMed Web of Science ®Google Scholar
• Rohlfs E M, Highsmith W E. PCR-based methods for mutation detection. Molecular Diagnostics: For the Clinical Laboratorian, W B Coleman, G J Tsongalis. Humana Press, Totowa, NJ 1997; 123–162
   Google Scholar
• Du Z, Hood L, Wilson R K. Automated fluorescent DNA sequencing of polymerase chain reaction products. Methods Enzymol 1993; 218: 104–121
   PubMed Web of Science ®Google Scholar
• Frohman M A. Cloning PCR products. The Polymerase Chain Reaction, K B Mullis, F Ferre, R A Gibbs. Birk-hauser, Boston 1994; 14–37
   Google Scholar
• Orita M., Suzuki Y, Sekiya T, et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874–879
   PubMed Web of Science ®Google Scholar
• Myers R M, Lumelsky N, Lerman L S, et al. Detection of single base substitutions in total genomic DNA. Nature 1985; 313: 495–498
   PubMed Web of Science ®Google Scholar
• Bhattacharyya A, Lilley D MJ. The contrasting structures of mismatched DNA sequences containing looped-out bases (bulges) and multiple mismatches (bubbles). Nucleic Acids Res 1989; 17: 6821–6840
   PubMed Web of Science ®Google Scholar
• Ferre F, Marchese A, Pezzoli P, . Quantitative PCR: an overview. The Polymerase Chain Reaction, K B Mullis, F Ferre, R A Gibbs, et al. Birkhauser, Boston 1994; 67–88
   Google Scholar
• Chelly J, Kahn A. RT-PCR and mRNA quantitation. The Polymerase Chain Reaction, K B Mullis, F Ferre, R A Gibbs. Birkhauser, Boston 1994; 97–109
   Google Scholar
• Maxam A M, Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol 1980; 65: 499–560
   PubMedGoogle Scholar
• Sanger F., Nicklen S, Coulson A R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463–5467
   PubMed Web of Science ®Google Scholar
• Smith L M, Sanders J Z, Kaiser R J, et al. Fluorescence detection in automated DNA sequence analysis. Nature 1986; 321: 674–679
   PubMed Web of Science ®Google Scholar
• Ansorge W, Sproat B S, Stegemann J, et al. A non-radioactive automated method for DNA sequence determination. J Biochem Biophys Methods 1986; 13: 315–23
   PubMedGoogle Scholar
• Highsmith W E, Silverman L. Evolution of automated molecular diagnostics. Clin Chem 1996; 9: 1367–1368
   Google Scholar
• Joshi V V, Tsongalis G J. Correlation between morphologic and nonmorphologic prognostic markers of neuroblastoma. Annals NY Acad Sci 1997; 824: 71–83
   PubMed Web of Science ®Google Scholar
• Seeger R C, Brodeur G M, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313: 1111–1116
   PubMed Web of Science ®Google Scholar
• Crabbe D CG, Peters J, Seeger R C. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagn Mol Pathol 1992; l(4)229–234
   Google Scholar
• Frye R A, Benz C C, Liu E. Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 1989; 4: 1153–1157
   PubMed Web of Science ®Google Scholar
• Gilbert J, Norris M D, Haber M, et al. Determination of N-mvc gene amplification in neuroblastoma by differential polymerase chain reaction. Molec Cell Probes 1993; 7: 227–234
   PubMed Web of Science ®Google Scholar
• Boerner S., Squire J, Thorner P, et al. Assessment of MYCN amplification in neuroblastoma biopsies by differential polymerase chain reaction. Pediatr Pathol 1994; 14: 823–832
   PubMed Web of Science ®Google Scholar
• Waha A, Rollbrocker B, Wiestler O D, et al. A polymerase chain reactio-based assay for the rapid detection of gene amplification in human tumors. Diagn Mol Pathol 1996; 5(2)147–150
   PubMed Web of Science ®Google Scholar
• Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients, i. Clin Oncol 1996; 14: 1245–1251
   Web of Science ®Google Scholar
• Sorensen P HB, Liu X F, Delattre O, et al. Reverse transcriptase PCR amplification of EWS/FL1–1 fusion transcripts as a diagn-sotic test for peripheral primitive neuroectodermal tumors of childhood. Diagn Mol Pathol 1993; 2(3)147–157
   PubMed Web of Science ®Google Scholar
• Thorner P, Squire J, Chilton-MacNeill, et al. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor. Am J Pathol 1996; 148: 1125–1138
   PubMed Web of Science ®Google Scholar
• Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors: a subgroup of small round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 331: 294–299
   PubMed Web of Science ®Google Scholar
• Zoubek A, Pfleiderer C, Salzer-Kuntschik M, et al. Variability of EWS chimaeric transcripts in Ewing tumors: a comparison of clinical and molecular data. Br J Cancer 1994; 70: 908–913
   PubMed Web of Science ®Google Scholar
• Parker S L, Tong T, Bolden S, et al. Cancer statistics, 1997. CA: Cancer J Clin 1997; 47: 5–27
   PubMed Web of Science ®Google Scholar
• Mandavilli S R, Cartun R W, Ricci A, Jr, et al. Immunohistochem-ical evaluation of genetic and epigenetic factors in primary breast cancers. J Histotechnol 1997; 20: 27–30
   Web of Science ®Google Scholar
• Marcus J N, Watson P, Page D L, et al. Herediatry breast cancer. Cancer 1996; 77: 697–709
   PubMed Web of Science ®Google Scholar
• Gayther Sa, Ponder B AJ. Mutations of the BRCAl and BRCA2 genes and the possibilities for predictive testing. Molec Med Today 1997; 3: 168–174
   PubMedGoogle Scholar
• Oddoux C, Struewing J P, Clayton C M, et al. The carrier frequency of the BRCA1 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 1996; 14: 188–190
   PubMed Web of Science ®Google Scholar
• Tavtigian S V, Simard J, Rommens J, et al. The complete BRCAl gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996; 12: 333–337
   PubMed Web of Science ®Google Scholar
• Couch F J, Weber B L. Breast Cancer Information Core: mutations and polymorphisms in the familial early-onset breast cancer (BRCAl) gene. Hum Mutat 1996; 8: 8–18
   PubMed Web of Science ®Google Scholar
• Tonin P, Weber B., Offit K, et al. Frequency of recurrent BRCA I and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 1996; 2: 1179–1183
   PubMed Web of Science ®Google Scholar
• Rohlfs E M, Learning W G, Friedman K J, et al. Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCAl by PCR-mediated site-directed mutagenesis. Clin Chem 1997; 43: 24–29
   PubMed Web of Science ®Google Scholar
• Offit K, Gilewski T., McGuire P, et al. Germline BRCAl 185de-1AG mutations in Jewish women with breast cancer. Lancet 1996; 347: 1643–1645
   PubMed Web of Science ®Google Scholar
• Roa B B, Boyd A A, Volcik K, et al. Ashkenazi Jewish population frequencies for common mutations in BRCAl and BRCAl. Nat Genet 1996; 14: 185–187
   PubMed Web of Science ®Google Scholar
• Haliassos A, Chomel J C, Tesson L, et al. Modification of enzy-matically amplified DNA for the detection of point mutations. Nucleic Acid Res 1989; 17: 3606–3610
   PubMed Web of Science ®Google Scholar
• Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: BRCAl and BRCAL. JAMA 1997; 277: 997–1003
   PubMed Web of Science ®Google Scholar